Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maabarot Products, also known as the Maabarot Group, is a prominent Israeli company specializing in the development, manufacturing, and marketing of health and nutrition products for humans and animals. The company operates through two primary divisions: the Health Division, which includes Altman Health (Israel's leader in dietary supplements) and Lavido (natural cosmetics), and the Animal Division, which features Biopet (pet food) and Halavit (livestock milk replacers). Historically recognized for founding the leading infant formula brand Materna, the group transitioned to a broader wellness and consumer healthcare focus after selling its remaining stake in Materna to Nestlé in 2017. Maabarot is publicly traded on the Tel Aviv Stock Exchange and continues to expand its portfolio through strategic acquisitions in the wellness and personal care sectors. The group maintains a strong market presence in Israel and is increasingly focusing on international expansion, particularly in the pet care and natural skincare markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maabarot Products.